David Morrow to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications David Morrow has written about Angiotensin Receptor Antagonists.
Connection Strength
0.307
-
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. Eur Heart J. 2019 10 21; 40(40):3345-3352.
Score: 0.249
-
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019 02 07; 380(6):539-548.
Score: 0.058